ESR Position Paper on Imaging Biobanks
暂无分享,去创建一个
[1] H. Longstaff,et al. Ethical Considerations in Biobanks: How a Public Health Ethics Perspective Sheds New Light on Old Controversies , 2015, Journal of Genetic Counseling.
[2] Daniel J Marcus,et al. Whitepapers on Imaging Infrastructure for Research Paper 3 . Security and Privacy , 2011 .
[3] Harry J de Koning,et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. , 2014, The Lancet. Oncology.
[4] W. Kannel,et al. The Framingham Study An Epidemiological Approach to Coronary Heart Disease , 1966, Circulation.
[5] S. Kardia,et al. Public Trust in Health Information Sharing: Implications for Biobanking and Electronic Health Record Systems , 2015, Journal of personalized medicine.
[6] Sharon F Terry,et al. Genetic Alliance Registry and BioBank: a novel disease advocacy-driven research solution. , 2011, Personalized medicine.
[7] Mithat Gönen,et al. Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment , 2015, Statistical methods in medical research.
[8] Rebecca O Barnes,et al. A proposed schema for classifying human research biobanks. , 2011, Biopreservation and biobanking.
[9] J. Cerhan,et al. Biobanks and personalized medicine , 2014, Clinical genetics.
[10] D. Cooper,et al. A legal framework for biobanking: the German experience , 2007, European Journal of Human Genetics.
[11] Paul M. Parizel,et al. European Society of Radiology (ESR) , 2015 .
[12] G. Bottiroli,et al. Autofluorescence Spectroscopy and Imaging: A Tool for Biomedical Research and Diagnosis , 2014, European journal of histochemistry : EJH.
[13] Robert Hewitt,et al. Defining biobank. , 2013, Biopreservation and biobanking.
[14] Mark Woodbridge,et al. MRIdb: Medical Image Management for Biobank Research , 2013, Journal of Digital Imaging.
[15] Kurt Zatloukal,et al. Biobanks: transnational, European and global networks. , 2007, Briefings in functional genomics & proteomics.
[16] F. Grannis. National lung screening trial limitations and public health policy. , 2014, Oncology.
[17] Marco Eichelberg,et al. Enhancing IHE XDS for Federated Clinical Affinity Domain Support , 2007, IEEE Transactions on Information Technology in Biomedicine.
[18] H. Barnhart,et al. The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions , 2015, Statistical methods in medical research.
[19] G. Ginsburg,et al. The path to personalized medicine. , 2002, Current opinion in chemical biology.
[20] J. Linseisen,et al. Public perceptions of cohort studies and biobanks in Germany. , 2014, Biopreservation and biobanking.
[21] Thomas Beyer,et al. Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR) , 2011, Insights into imaging.
[22] V. Yaghmai,et al. A radiologist's guide to treatment response criteria in oncologic imaging: functional, molecular, and disease-specific imaging biomarkers. , 2013, AJR. American journal of roentgenology.
[23] F. Moll,et al. Biobanking in Atherosclerotic Disease, Opportunities and Pitfalls , 2011, Current cardiology reviews.
[24] Robert E. Hewitt,et al. Biobanking: the foundation of personalized medicine , 2011, Current opinion in oncology.
[25] Tony Pan,et al. Imaging Infrastructure for Research. Part 2. Data Management Practices , 2012, Journal of Digital Imaging.
[26] Jeffrey W. Prescott,et al. Quantitative Imaging Biomarkers: The Application of Advanced Image Processing and Analysis to Clinical and Preclinical Decision Making , 2013, Journal of Digital Imaging.
[27] Tony Pan,et al. Whitepapers on Imaging Infrastructure for Research , 2012, Journal of Digital Imaging.
[28] European Society of Radiology. ESR statement on the stepwise development of imaging biomarkers , 2013, Insights into Imaging.
[29] Tony Pan,et al. Whitepapers on Imaging Infrastructure for Research Part Three: Security and Privacy , 2012, Journal of Digital Imaging.
[30] Arash Naeim,et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. , 2014, The New England journal of medicine.
[31] K. Hahm,et al. Molecular Imaging for Theranostics in Gastroenterology: One Stone to Kill Two Birds , 2014, Clinical endoscopy.
[32] Jodyn Platt,et al. Public preferences regarding informed consent models for participation in population-based genomic research , 2013, Genetics in Medicine.
[33] P. Matthews,et al. Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches , 2013, Journal of Cardiovascular Magnetic Resonance.
[34] StarkbaumJohannes,et al. Public perceptions of cohort studies and biobanks in Germany. , 2014 .
[35] Osman Ratib,et al. Structured reporting: a fusion reactor hungry for fuel , 2014, Insights into Imaging.
[36] C. Hassan,et al. Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial , 2014, Trials.
[37] M. Mascalchi,et al. Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study) , 2013, Trials.
[38] Leonard W. D'Avolio,et al. Detours on the road to personalized medicine: barriers to biomarker validation and implementation. , 2011, JAMA.
[39] Bok-Ghee Han,et al. Current Status, Challenges, Policies, and Bioethics of Biobanks , 2013, Genomics & informatics.